Schwarz, T <br/><br/>
Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study.  [electronic resource] 

 -  BJOG : an international journal of obstetrics and gynaecology  Jan 2015 
 - 107-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-0528 
<br/><br/><label>Standard No.: </label>10.1111/1471-0528.13070  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Antibodies, Viral--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Follow-Up Studies<br/>Human papillomavirus 16--immunology<br/>Human papillomavirus 18--immunology<br/>Humans<br/>Middle Aged<br/>Papillomavirus Infections--prevention & control<br/>Papillomavirus Vaccines--immunology<br/>Uterine Cervical Neoplasms--prevention & control<br/>Young Adult